AVITA director buys 10,000 shares in open market
AVITA Medical, Inc. director Woody Joseph Fralin reported buying a total of 10,000 shares of the company’s Common Stock in open-market transactions.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
AVITA Medical, Inc. director Woody Joseph Fralin reported buying a total of 10,000 shares of the company’s Common Stock in open-market transactions. The purchases on June 3, 2026 were made at prices of $4.0899 and $4.0999 per share.
After these trades, Fralin directly holds 92,761 shares of AVITA Medical common stock, which the disclosure notes includes unvested restricted stock units (RSUs). These are straightforward open-market purchases, increasing his direct equity stake in the company.
Insider Trade Summary
Net Buyer: 10,000 shares
Net Buy
2 txns
Insider
Woody Joseph Fralin
Role
Director
Bought
10,000 shs ($41K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 5,000 | $4.0999 | $20K |
| Purchase | Common Stock | 5,000 | $4.0899 | $20K |
Holdings After Transaction:
Common Stock — 92,761 shares (Direct)
Footnotes (1)
- F1. Includes unvested RSUs
Key Figures
Total shares bought: 10,000 shares
First purchase price: $4.0899 per share
Second purchase price: $4.0999 per share
+2 more
5 metrics
Total shares bought
10,000 shares
Two open-market purchases of Common Stock on June 3, 2026
First purchase price
$4.0899 per share
5,000-share open-market purchase of Common Stock
Second purchase price
$4.0999 per share
5,000-share open-market purchase of Common Stock
Shares owned after trades
92,761 shares
Direct holdings after purchases, includes unvested RSUs
Number of buy transactions
2 purchases
Both coded P as open-market or private purchases
Key Terms
open-market purchase, restricted stock units (RSUs), Common Stock, Form 4
4 terms
open-market purchase financial
"Transaction action is described as an open-market purchase of Common Stock."
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
restricted stock units (RSUs) financial
"A footnote notes that the reported holdings include unvested RSUs."
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
Common Stock financial
"Both transactions involve purchases of the issuer’s Common Stock."
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"The insider transaction is disclosed in a Form 4 filing."
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did AVITA Medical (RCEL) disclose for Woody Joseph Fralin?
AVITA Medical disclosed that director Woody Joseph Fralin bought 10,000 shares of Common Stock. The Form 4 shows two open-market purchases on June 3, 2026, increasing his direct holdings in the company’s shares, including unvested RSUs.
Were the AVITA Medical (RCEL) insider transactions open-market buys or another type?
The transactions were open-market purchases of Common Stock. The Form 4 uses transaction code P and describes each as a “Purchase in open market or private transaction,” with transaction_direction classified as “buy” for both 5,000-share trades.
Does the AVITA Medical (RCEL) Form 4 mention any derivative securities or options?
The Form 4 does not show any derivative transactions for this event. The derivativeSummary section is empty, indicating no reported option exercises, warrants, or other derivative securities associated with these particular insider purchases.
Are unvested RSUs included in the AVITA Medical (RCEL) director’s reported holdings?
Yes, unvested RSUs are included in the reported holdings. A footnote to the Form 4 explicitly states “Includes unvested RSUs,” meaning the 92,761-share total reflects both common shares and unvested restricted stock units.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates